Literature DB >> 1846019

Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors.

I Zvibel1, E Halay, L M Reid.   

Abstract

Highly sulfated, heparinlike species of heparan sulfate proteoglycans, with heparinlike glycosaminoglycan chains, are extracellular matrix components that are plasma membrane bound in growth-arrested liver cells. Heparins were found to inhibit the growth and lower the clonal growth efficiency of HepG2, a minimally deviant, human hepatoma cell line. Heparan sulfates, closely related glycosaminoglycans present in the extracellular matrix around growing liver cells, had no effect on the growth rate or clonal growth efficiency of HepG2 cells. Neither heparins nor heparan sulfates had any effect on the growth rate or clonal growth efficiency of two poorly differentiated, highly metastatic hepatoma cell lines, SK-Hep-1 and PLC/PRF/5. Heparin's inhibition of growth of HepG2 cells correlated with changes in the mRNA synthesis and abundance of insulinlike growth factor II (IGF II) and transforming growth factor beta (TGF beta). HepG2 cells expressed high basal levels of mRNAs encoding IGF II and TGF beta that were inducible, through transcriptional and posttranscriptional mechanisms, to higher levels by specific heparin-hormone combinations. For both IGF II and TGF beta, the regulation was multifactorial. Transcriptionally, IGF II was regulated by the additive effects of insulin, glucagon, and growth hormone in combination with heparin; TGF beta was regulated primarily by the synergistic effects of insulin and growth hormone in combination with heparin. Posttranscriptionally, the mRNA abundance of the IGF II 4.5- and 3.7-kb transcripts was affected by insulin. Heparin induction of all IGF II transcripts was also dependent on triiodotyronine and prolactin, but it is unknown whether their induction by heparin was via transcriptional or posttranscriptional mechanisms. Heparin-insulin combinations regulated TGF beta posttranscriptionally. The poorly differentiated hepatoma cell lines PLC/PRF/5 and SK-Hep-1 either did not express or constitutively expressed low basal levels of IGF I, IGF II, and TGF beta, whose mRNA synthesis and abundance showed no response to any heparin-hormone combination. We discuss the data as evidence that matrix chemistry is a variable determining the expression of autocrine growth factor genes and the biological responses to them.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846019      PMCID: PMC359598          DOI: 10.1128/mcb.11.1.108-116.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Enhanced expression of insulin-like growth factor II is not a necessary event in Wilms' tumour progression.

Authors:  M H Little; G Ablett; P J Smith
Journal:  Carcinogenesis       Date:  1987-06       Impact factor: 4.944

2.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

Authors:  R P Penttinen; S Kobayashi; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  The inhibition of low density lipoprotein metabolism by transforming growth factor-beta mediates its effects on steroidogenesis in bovine adrenocortical cells in vitro.

Authors:  M Hotta; A Baird
Journal:  Endocrinology       Date:  1987-07       Impact factor: 4.736

5.  Characterization of the insulin and insulin-like growth factor receptors and responsitivity of a fibroblast/adipocyte cell line before and after differentiation.

Authors:  M Shimizu; F Torti; R A Roth
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

6.  Transcriptional deviation of the rat insulin-like growth factor II gene initiated at three alternative leader-exons between neonatal tissues and ascites hepatomas.

Authors:  T Ueno; K Takahashi; T Matsuguchi; H Endo; M Yamamoto
Journal:  Biochim Biophys Acta       Date:  1988-09-07

7.  The human insulin-like growth factor II gene contains two development-specific promoters.

Authors:  P de Pagter-Holthuizen; M Jansen; F M van Schaik; R van der Kammen; C Oosterwijk; J L Van den Brande; J S Sussenbach
Journal:  FEBS Lett       Date:  1987-04-20       Impact factor: 4.124

8.  Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF.

Authors:  T C Wright; T V Johnstone; J J Castellot; M J Karnovsky
Journal:  J Cell Physiol       Date:  1985-12       Impact factor: 6.384

9.  Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.

Authors:  C F Reilly; L M Fritze; R D Rosenberg
Journal:  J Cell Physiol       Date:  1987-05       Impact factor: 6.384

10.  Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C C Pao; C M Chu; I S Sheen; M J Huang
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

View more
  9 in total

Review 1.  Stem cell-fed maturational lineages and gradients in signals: relevance to differentiation of epithelia.

Authors:  L M Reid
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

2.  Heparin inhibits Ca2+/calmodulin-dependent kinase II activation and c-fos induction in mesangial cells.

Authors:  T Miralem; D M Templeton
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Insulin-like growth factor-II receptor expression in normal and N-methyl-N'-nitro-nitrosoguanidine exposed cell lines: assessment by flow cytometry.

Authors:  W H Thornton; L Barnett; R S MacDonald
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

4.  Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.

Authors:  J Dudás; G Ramadori; T Knittel; K Neubauer; D Raddatz; K Egedy; I Kovalszky
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

5.  Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.

Authors:  L A Cupelli; J Lenz
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.

Authors:  L A Cupelli; M C Hsu
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas.

Authors:  T García-Caballero; H M Mertani; A Lambert; R Gallego; M Fraga; E Pintos; J Forteza; M Chevallier; P E Lobie; B K Vonderhaar; A Beiras; G Morel
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

8.  Antiproliferative Activity of Cinnamomum cassia Constituents and Effects of Pifithrin-Alpha on Their Apoptotic Signaling Pathways in Hep G2 Cells.

Authors:  Lean-Teik Ng; Shu-Jing Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-02       Impact factor: 2.629

9.  Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts.

Authors:  K Gohji; M Nakajima; A Fabra; C D Bucana; A C von Eschenbach; T Tsuruo; I J Fidler
Journal:  Jpn J Cancer Res       Date:  1994-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.